ANTIMICROBIAL RESISTANCE

Similar documents
ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

4. The use of antibiotics without a prescription in seven EU Member States

ANTIMICROBIAL STEWARDSHIP IN PRIMARY CARE DR ROSEMARY IKRAM MBBS FRCPA CLINICAL MICROBIOLOGIST

Antimicrobial Stewardship: Setting minimum expectations for optimizing antimicrobial use and addressing resistance

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

3. Explaining differences in antibiotic use across the EU

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

Using Data to Track Antibiotic Use and Outcomes

Global Communication on AMR in Animal Health: Tripartite and OIE Efforts

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

First-year experiences in implementing Thailand s National Strategic Plan on AMR

Highlights on Hong Kong Strategy and Action Plan on Antimicrobial Resistance ( ) (Action Plan)

OIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools

WORLD ANTIBIOTIC AWARENESS WEEK

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Quality indicators and outcomes in the devolved nations Scotland

Antimicrobial Stewardship

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Healthcare Facilities and Healthcare Professionals. Public

EU strategy to fight against Antimicrobial Resistance

OIE strategy on AMR and the Prudent Use of Antimicrobials

FAO-OIE-WHO Tripartite Positions and Actions on Antimicrobial Resistance (AMR)

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi

W O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p

Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016

The European AMR Challenge - strategic views from the human perspective -

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

WELSH HEALTH CIRCULAR

Antimicrobial Stewardship: The South African Perspective

OIE AMR Strategy, One Health concept and Tripartite activities

Request for advice on the impact on public health and animal health of the use of antibiotics in animals

Changing behaviours in antimicrobial stewardship

For Alberta broiler producers, the biggest impacts will be:

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

Health and Food Safety. EU Guidelines for the prudent use of antimicrobials in human health

TREAT Steward. Antimicrobial Stewardship software with personalized decision support

CHAPTER 9 ANTIMICROBIAL STEWARDSHIP PROGRAM (ASP)

Impact of Antimicrobial Stewardship Program

Antibiotic stewardship a role for Managed Care. Doug Burgoyne, PharmD. CEO, Veridicus Health

Consultation on a draft Global action plan to address antimicrobial resistance

Surveillance of AMR in PHE: a multidisciplinary,

Antimicrobial Stewardship in the Hospital Setting

Hospital Antimicrobial Stewardship Program Assessment Checklist

BELIEFS AND PRACTICES OF PARENTS ON THE USE OF ANTIBIOTICS FOR THEIR CHILDREN WITH UPPER RESPIRATORY TRACT INFECTION

Government Initiatives to Combat Antimicrobial Resistance (AMR)

Control and monitoring of the use of antibiotics as a strategy against antimicrobials resistance

Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts

ANTIMICROBIAL RESISTANCE THE AUSTRALIAN CONTEXT. Professor Brendan Murphy Australian Government Chief Medical Officer

Monthly Webinar. Tuesday 16th January 2018, 16:00. That Was The Year That Was : Selections from the 2017 Antimicrobial Stewardship Literature

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

Promoting One Health : the international perspective OIE

Antimicrobial Resistance, yes we care! The European Joint Action

National Action Plan development support tools

COST-EFFECTIVENESS OF INTERVENTIONS TO LIMIT THE SPREAD OF AMR A PERSPECTIVE FROM THE OECD

Antibiotic stewardship Implementing Strategies

Charlotte Maxeke Academic Hospital (CMAH)

Antimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson

Antimicrobial Stewardship. Where are we now and where do we need to go?

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

R E S O U R C E S T O O L K I T F O R H E A L T H C A R E P R O F E S S I O N A L S A N D P R O F E S S I O N A L B O D I E S I N E N G L A N D

English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

Bacteria become resistant to antibiotics- not humans or animals.

What is an Antibiotic Stewardship Program?

PGEU GPUE Pharmaceutical Group of European Union Groupement

DANMAP and VetStat. Monitoring resistance and antimicrobial consumption in production animals

COMMISSION OF THE EUROPEAN COMMUNITIES

AMR situation in Europe: Strategy and vision

Antibiotic Stewardship in the LTC Setting

European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe

EDUCATION OF HEALTHCARE PROFESSIONALS ON PRUDENT USE OF ANTIBIOTICS: ROOM FOR IMPROVEMENT

FVE and responsible use of antimicrobials

EFSA-EMA Joint Scientific Opinion

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

Antibiotic resistance: Prioritising the patient

Combat Antimicrobial Resistance

Action for Combatting AMR in Veterinary Sector

HMA-V Action plan on antimicrobial issues Version for publication (27 January 2011)

Core Elements of Antibiotic Stewardship for Nursing Homes

Quality and Safety Committee

POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS

Identifying Medicine Use Problems Using Indicator-Based Studies in Health Facilities

Jump Start Stewardship

Measures relating to antimicrobial resistance (AMR)

Antimicrobial Stewardship

Consultation on a draft Global action plan to address antimicrobial resistance

European Antibiotic Awareness Day

GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT

Antimicrobial stewardship

Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton

Third Global Patient Safety Challenge. Tackling Antimicrobial Resistance

CLINICAL AUDIT. Prescribing amoxicillin clavulanate appropriately

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

Role of the Veterinary Statutory Bodies (VSB) for Good Veterinary Governance.

Managing winter illnesses without antibiotics

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

Transcription:

Session 4: How to join efforts for improving communication, education and training Prescription by general practitioners/family physicians ANTIMICROBIAL RESISTANCE Walter Marrocco EFPC September 19 th 2017 - EMA

USE OF ANTIBIOTICS IN GPs SETTING The use of antibiotics occurs within the context of healthcare systems that vary widely for the health needs of Individuals groups communities wider society due to differences in political, historical, cultural and socioeconomic traditions: the organisational arrangements for healthcare differ considerably between EU Member States variation in the use of medicines is largely determined by each Member State s healthcare system Cars et al. The Lancet, Vol. 357, No 9271, 2001, pp. 1851-1853 Deschepper et al. Pharmacoepidemiology and Drug Safety, Vol. 20, No 3, 2011, pp. 265-271

Key factors that drive the non-prudent use of antibiotics An integrated approach to understand the causes at different levels: 1) healthcare-system level the cultural background and regulations within the healthcare setting availability and access to antibiotics the way antibiotics are dispensed the existence of national guidelines for the use of antibiotics and the culture within a country regarding the use of antibiotics ARNA Study Antimicrobial resistance and the causes of non-prudent use of antibiotics April 2017

Key factors that drive the non-prudent use of antibiotics An integrated approach to understand the causes at different levels: 2) healthcare-professional level the behaviour of prescribers on prescribing and pharmacists the OTC dispensing of antibiotics ARNA Study Antimicrobial resistance and the causes of non-prudent use of antibiotics January 2017

Key factors that drive the non-prudent use of antibiotics An integrated approach to understand the causes at different levels: 3) patient level the knowledge the attitudes the costs of the doctor s consultation and of the antibiotics ARNA Study Antimicrobial resistance and the causes of non-prudent use of antibiotics April 2017

To understand the phenomenon To collect information on measures and interventions To analize the literature Survey among HNS/National experts The use of antibiotics without a prescription Increased from 5 % of all antibiotics used in 2013 to 7 % in 2016 (Arna Study 2017) Two prevailing sources of antibiotics without a prescription: OTC selling in pharmacies the use of leftover antibiotics

INTERVENTION approach likely to be most effective Multi-actors (Patients Pharmacists GPs) Multi-focused (different ways to approach the antibiotics)

In some European Countries INTERVENTIONS ON HCP LEVEL (GPs) multiple demand-side measures introduced following increased utilization significantly decreased subsequent antibiotic utilization and associated costs. additional targeted activities are planned to further reduce antibiotic prescribing and resistance. the choice of an antibiotic agent should therefore be guided by the resistance pattern of the pathogen causing the infection to be treated [Warren et al, 1999]. information on the resistance pattern in a population is therefore valuable for: a) assessing the appropriateness of the prescribing b) formulating guidelines APRES study 2015

COMMITMENT for HCPs HCPs should also be made familiar with guidelines for the prudent use of antibiotics Continuous Education programmes and lifelong learning Material available to GPs for patient information/education Communication skills of HCPs towards their patients, taking into account the health literacy of patients

TOOLS OF INTERVENTION in GPs Setting 1) DIAGNOSTIC TESTS 2) PREVENTIVE VACCINES PROMOTING USE OF Vaccines: crucial and very cost-effective in preventing the onset and spread of infectious diseases Vaccines: great potential to reduce the incidence of AMR Support increasing the knowledge base concerning the barriers for a wider use of vaccination A European One Health Action Plan against Antimicrobial Resistance (AMR)

Antimicrobial Resistance (AMR) Toolkit for Public Engagement A toolkit designed to support you or your organisation in engaging with members of the public on AMR April 2017

A lack of relevant national data on resistance OPTIMA STUDY what s next? (OPtimizing Antibiotic use in Primary Care) GPs and Pharmacists: 1) Questionnaires on prescription and dispensing habits, attitudes towards antibiotics, communication techniques, information to patients. 2) Data on antibiotics consumption: volume, first choice.

A lack of relevant national data on resistance what s next? A Survey on Primary Care titled AMR IN GPs SETTING (ongoing in Italy) which can support the EMA s task on: Information, Communication Tools, Research Project, etc., in the context of EMA s work with GPs. About many topics: Type and frequency of infections observed by GPs Clinical presentation (duration of symptoms, organs affected) Accessibility / availability of biological antibiogram material Availability of antibiogram labs in the area of membership (mapping of possible deficiencies) Antibiogram request or other examinations Antibiogram response times Prescription before laboratory response Action after laboratory response...